Imago BioSciences logo

Imago BioSciences

About

Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor

Org chart

View all (6)
Hugh Y. Rienhoff
Hugh Y. Rienhoff
Hugh Y. Rienhoff
CEO
Amy E. Tapper
Amy E. Tapper
Amy E. Tapper
SVP, Non-Clinical and CMC
Ed Baracchini
Ed Baracchini
Ed Baracchini
Chief Business Officer
Jennifer Peppe
Jennifer Peppe
Jennifer Peppe
SVP, Clinical Operations
Laura G. Eichorn
Laura G. Eichorn
Laura G. Eichorn
COO
Bob Baltera
Director

Jobs

View all (0)

No jobs yet!

Wires

View all (0)

No wires yet!

Similar companies

Roivant Sciences logo
Roivant Sciences
ElevateBio logo
ElevateBio
AVROBIO logo
AVROBIO
Ionis Pharmaceuticals logo
Ionis Pharmaceuticals
Emergent BioSolutions logo
Emergent BioSolutions
Agilent Technologies logo
Agilent Technologies
Regeneron logo
Regeneron
Moderna Therapeutics logo
Moderna Therapeutics
Thermo Fisher Scientific logo
Thermo Fisher Scientific
23andMe logo
23andMe
Amgen logo
Amgen
Genentech logo
Genentech
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.